In cancer models such as breast and pancreatic carcinoma, CCN5 exerts its biological effects through autocrine or paracrine mechanisms to modulate WNT signaling and other pathways, particularly influencing the endothelial–mesenchymal transition process [14–16]. Here, CCN5 is linked to cancer.